Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium
NCT04117386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141
Last updated 2020-07-14
Summary
Prevalence of HPV-associated eye infection and cytokine levels in tears from patients diagnosed with pterygium
Conditions
- Human Papilloma Virus Infection
- Pterygium
Interventions
- DIAGNOSTIC_TEST
-
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)
- DIAGNOSTIC_TEST
-
Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Sponsors & Collaborators
-
Chulalongkorn University
lead OTHER
Principal Investigators
-
Ngamjit Kasetsuwan · Department of Ophthalmology, Chulalongkorn University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2020-04-30
- Completion
- 2020-06-15
Countries
- Thailand
Study Locations
More Related Trials
-
Merck IIT: RRP Pembro and Lenvatinib
NCT04645602 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
NCT02376478 ·Status: COMPLETED
-
Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
NCT02710851 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
NCT03911076 ·Status: TERMINATED ·Phase: PHASE2
-
Immunotherapy in Eyelid Viral Papilloma
NCT06720467 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers
NCT03912831 ·Status: TERMINATED ·Phase: PHASE1
-
The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
NCT00002327 ·Status: COMPLETED ·Phase: PHASE1
-
Study of FluBHPVE6E7 in HPV-16 Infected Women
NCT04490512 ·Status: COMPLETED ·Phase: PHASE1
-
BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
NCT04528407 ·Status: COMPLETED
-
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
NCT00001126 ·Status: COMPLETED ·Phase: PHASE1
-
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
NCT04724980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)
NCT02761122 ·Status: COMPLETED ·Phase: NA
-
Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis
NCT01375868 ·Status: COMPLETED ·Phase: PHASE3
-
Avelumab for People With Recurrent Respiratory Papillomatosis
NCT02859454 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
NCT00038714 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
NCT05584332 ·Status: TERMINATED ·Phase: PHASE3
-
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453
NCT02052687 ·Status: COMPLETED ·Phase: PHASE1
-
Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
NCT02631863 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies
NCT02241369 ·Status: COMPLETED ·Phase: PHASE1
-
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
NCT02546752 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
NCT02301494 ·Status: WITHDRAWN ·Phase: NA
-
Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
NCT00829608 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
NCT02724254 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test
NCT06188104 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
NCT04630353 ·Status: TERMINATED ·Phase: EARLY_PHASE1